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CDC Convenes Meeting to Discuss
Strategies for Preventing Invasive
Group A Streptococcal Infections
Since the mid-1980s, the epidemiology of inva-
sive group A streptococcal (GAS) infections in the
United States and worldwide has changed, and
the incidence of invasive infections, streptococcal
toxic shock syndrome (strep TSS), and necrotizing
fasciitis has increased. These changes may be the
result of a shift in GAS M-types and a correspond-
ing increase in strains that produce certain
pyrogenic exotoxins. Recognizing the importance
of monitoring changes in the occurrence of severe
group A streptococcal disease, the Council of State
and Territorial Epidemiologists recommended in
April 1995 that invasive GAS infections and strep
TSS be added to the National Public Health Sur-
veillance System.
Most invasive GAS infections occur sporadi-
cally and are acquired in the community. For these
cases, preventing illness and death depends on
improving recognition and treatment. Primary
prevention of invasive GAS disease may be more
feasible for infections that are acquired in institu-
tions (such as hospitals and nursing homes) and
for secondary cases that occur among contacts of
persons with invasive disease. Most nosocomial
infections (for example, wound infections, postpar-
tum endometritis, and sepsis) occur in surgical or
obstetric settings, or are associated with intrave-
nous catheters. Secondary invasive disease in the
community is uncommon, although studies of
household contacts of those with GAS infection-
shave found a substantially increased risk for
infection in this group. GAS infections spread
easily from person to person after contact with
respiratory secretions of an infected person and
have traditionally caused epidemics of pharyngi-
tis, scarlet fever, and rheumatic fever. Recently,
clusters of invasive infections have been reported
in families, hospitals, and nursing homes; commu-
nity-wide outbreaks have also been reported.
As state health departments initiate surveil-
lance for invasive GAS disease and strep TSS,
guidelines for prevention will help in interpreting
these data and in formulating a public health
response. CDC convened a meeting of experts from
academia and public health (October 10-11, 1995),
to discuss existing data and strategies for prevent-
ing invasive GAS disease in institutions and the
community. Discussions centered on the
magnitude of risk for secondary disease among
close contacts of persons with invasive infection
and the potential for preventing disease by chemo-
prophylaxis, and on approaches for investigating
and preventing infections in institutions. Recom-
mendations are being developed, and the conclu-
sions of the participants will be presented at a later
date.
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Regional Conference on Emerging
Infectious Diseases Sparks Plan for
Increased Collaboration
The World Health Organization (WHO), the
Naval Medical Research Unit Three (NAMRU-3),
and the Centers for Disease Control and Preven-
tion (CDC) jointly sponsored the first conference
in the region on issues of emerging and ree-
merging infectious diseases for members of WHO’s
Eastern Mediterranean Regional Office (EMRO).
The meeting was held in Cairo, Egypt, November
26-29, 1995. Delegates from the WHO South-East
Asia Regional Office and African Regional Office
also participated.
The meeting brought together persons repre-
senting key resources that have begun working
together to organize a regional program of
laboratory assistance and enhanced surveillance
communications for infectious diseases. Partici-
pants included WHO infectious disease program
officers and key personnel from WHO collaborat-
ing centers, national reference laboratories, na-
tional infectious disease programs, ministries of
health, and university public health programs.
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200 participants. On the final day of the confer-
ence, the participants adopted a regional plan of
action for strengthening surveillance, laboratory
capabilities, and communications.
To begin this cooperative effort, a 1-day meeting
of WHO-EMRO collaborating centers was con-
vened on November 30. Representatives from six
EMRO collaborating centers attended as well as
representatives from WHO-EMRO, WHO head-
quarters, CDC, the Naval Medical Research Insti-
tute in Washington, D.C., and the Battelle
Foundation.
Participants noted that WHO collaborating
centers are an excellent resource for the imple-
mentation of programs to address emerging infec-
tions because they represent some of the most
competent and experienced diagnostic and refer-
ence capacities in the region.  However, the repre-
sentatives agreed that the relationships among
the collaborating centers themselves are not well
developed.  Many were unaware of the existence
or capabilities of most other regional collaborating
centers and most had no regular communications
or interactions with other collaborating centers.
All welcomed closer ties with an increase in com-
munication, collaboration, and interaction.
The participants unanimously approved a rec-
ommendation to establish an Association of
EMRO collaborating centers composed of repre-
sentatives from each WHO collaborating center
within the region. Member organizations of the
association will work together, in coordination
with EMRO, to address the complex needs of sur-
veillance, laboratory diagnostics, and disease re-
porting of emerging infections at the local and
regional level.
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